Contact
QR code for the current URL

Story Box-ID: 58225

ProBioGen AG Goethestr. 54 13086 Berlin, Germany http://www.probiogen.de
Contact Dr. Hing Kin Chan +49 30 924006147
Company logo of ProBioGen AG
ProBioGen AG

ProBioGen Signed Agreement on Testing of Neuronal Cell Lines with Serono

(PresseBox) (Berlin, )
ProBioGen AG announced today that Serono S.A., Switzerland has signed an Agreement to evaluate ProBioGen's novel human neuronal cell line for the production of recombinant proteins.

Under the terms of the Agreement, Serono will explore the feasibility of using the proprietary neuronal cell line of ProBioGen as a host for the production of recombinant proteins. Financial details are not disclosed.

“Our human neuronal cell lines not only have the advantage of producing proteins with human glycosylation patterns, but they also have been developed with a fully documented history, a very important prerequisite for smooth approval of products derived from a cell line," said Michael Schlenk, CEO of ProBioGen AG. "In addition, they have a very high productivity, so we think we have created cell lines that can produce human biopharmaceuticals very cost effectively and with a very high safety profile. We are very glad that we won Serono as the first partner to explore the huge potential of these cell lines as Serono has a lot of experience in developing recombinant proteins.”

ProBioGen AG

ProBioGen is a cell specialist. By combining deep molecular understanding of cells with state-of-the-art industry process engineering and production know-how, ProBioGen's technologies enable biopharmaceutical companies to develop products with superior efficiency, safety and a more favourable cost profile. Since its inception in 1994, the company has processed more than 300 cell lines and established a GMP unit based on disposable reactor technology, which supports all currently available manufacturing processes. The company is headquartered in Berlin.

For more information, please visit www.probiogen.de

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2023, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.